Japan Tissue Engineering Co., Ltd. (JP:7774) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Japan Tissue Engineering Co., Ltd. reports a decline in financial performance in the first quarter of FY2024 with net sales down by 33.2% and a net loss of 211 million yen, contrasting the positive figures from the previous year. The company’s total assets decreased slightly, while the equity ratio improved to 88.5%. No dividends were paid in FY2023, and the same is forecasted for FY2024.
For further insights into JP:7774 stock, check out TipRanks’ Stock Analysis page.